-
Forward Look
Young Survivors at Risk for HPV-Related CancersStudy finds low vaccination rates among teen survivors.
by Kate Yandell
-
Targeting Brain CancerResearchers are trying to understand brain cancer at the molecular level. Their goal is to find new, more effective therapies for this hard-to-treat disease.
by Stephen Ornes
-
Survivor Profile
A Second ChanceAfter the deaths of her sister and mother from cancer and a bout with osteosarcoma as a teenager, Court Simmons vowed to “do something amazing” with her life. Her goal is to be a pediatric oncology nurse.
by Lindsey Konkel
-
Cancer Control in the CommunitySuccessful public health initiatives to prevent, detect and treat cancer require widespread community participation.
by Marci A. Landsmann
-
Breaking Down a Cancer DiagnosisDuring her husband's treatment for metastatic prostate cancer, Jan Manarite learned what questions to ask. Now she shares what she learned with others.
by Marci A. Landsmann
-
Challenges Remain for Kids With CancerMore children are being treated successfully for cancer. Yet researchers continue searching for new therapies that will help kids who don't respond to standard treatments.
by Cameron Walker
-
-
Vaccines: Looking Within for Cancer TreatmentResearchers are testing treatment vaccines that spur the immune system to attack cancer.
by Stephen Ornes
-
Advocacy in Action
Fearless FriendsLori Marx-Rubiner and AnneMarie Ciccarella met on social media and grew close through their cancer research advocacy.
by Sue Rochman
-
Q&A
Trial GuideResearcher Tom Marsilje is helping fellow colorectal cancer patients sort through clinical trials.
by Kate Yandell
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
